Caterina Violi, MD
Obstetrics & Gynecology · Greenwich, CTNPI 1942395777
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 362 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 31.7% of the total. Reporting peaked in 2019 at $1,566 and has fallen 55.8% since, to $693 in 2025. Among obstetrics & gynecology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 362 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Mayne Pharma Commercial LLC$794
- Avion Pharmaceuticals$606
- Exeltis, USA Inc.$506
- Exact Sciences$414
- Pfizer$266
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,425100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 127 | $2,044 |
| Mayne Pharma Commercial LLC | 39 | $794 |
| Avion Pharmaceuticals | 42 | $606 |
| Exeltis, USA Inc. | 42 | $506 |
| Exact Sciences | 15 | $414 |
| Pfizer | 12 | $266 |
| Medtronic(2 entities) | 9 | $257 |
| Vertical Pharmaceuticals, LLC | 14 | $230 |
| Therapeuticsmd, Inc. | 10 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $159 |
| Myovant Sciences Inc. | 7 | $155 |
| Sumitomo Pharma America, Inc. | 6 | $132 |
| Agile Therapeutics, Inc. | 4 | $88 |
| Coopersurgical, Inc. | 5 | $82 |
| Millicent US Inc | 5 | $79 |
| Biogen | 3 | $73 |
| Aspira Women's Health Inc | 1 | $70 |
| Medicem Inc. | 4 | $57 |
| Scynexis, Inc. | 2 | $47 |
| Bayer | 2 | $41 |
| Roche Diagnostics Corporation | 1 | $24 |
| Abbott | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Mission Pharmacal Company | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Channel Medsystems, Inc. | 1 | $14 |
How this compares
$6,442 in reported general payments places this provider in the 95th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 12 | $432 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Greenwich
- Mary MinkinNew Haven$285K
- Alessandro SantinNew Haven$98K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Shieva GhofranyStamford$33K
- Mark LeondiresNorwalk$31K
- Alan FineHartford$30K
- Sean FlahertyHamden$28K
- Adam SteinbergHartford$23K
- Sarp AkselStamford$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.